Showing results (1961-1970 of 2,487) with videos related to

Sort By:
Pageof 249
Journal of Translational Medicine|March 8, 2024
Inhibition of OGFOD1 by FG4592 confers neuroprotection by activating unfolded protein response and autophagy after ischemic strokeJian Xie, Yuan Zhang, Bin Li, et al.
ACS Pharmacology & Translational Science|March 14, 2024
miR-873-5p Suppression Reinvigorates Aging Mesenchymal Stem Cells and Improves Cardiac Repair after Myocardial InfarctionWenwu Zhu, Wei Du, Rui Duan, et al.
Gut Microbes|July 11, 2023
Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitisBing Han, Xiaodan Lv, Gengfeng Liu, et al.
Frontiers in Oncology|November 11, 2021
Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival PrognosisDingan Luo, Deze Zhao, Mao Zhang, et al.
Environmental Toxicology|November 12, 2021
Microcrystalline silica particles induce inflammatory response via pyroptosis in primary human respiratory epithelial cellsShangya Chen, Bing Han, Xiao Geng, et al.
Archives of Toxicology|March 13, 2021
Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modelingSize Li, Yiqun Yu, Xiaolan Bian, et al.
European Journal of Medicinal Chemistry|June 24, 2019
Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agentsApeng Wang, Kai Lv, Linhu Li, et al.
Antioxidants & Redox Signaling|June 11, 2020
Selenium Status in Diet Affects Acetaminophen-Induced Hepatotoxicity <i>via</i> Interruption of Redox EnvironmentJing Li, Ping Cheng, Shoufeng Li, et al.
Endocrine|March 6, 2017
Follicle stimulating hormone, its novel association with sex hormone binding globulin in men and postmenopausal womenNingjian Wang, Kun Zhang, Bing Han, et al.
International Journal of Hematology|March 1, 2021
Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatmentYumei Liu, Chen Yang, Hua Xue, et al.
Pageof 249